老年人终末期肾病血液透析临床剖析.docVIP

老年人终末期肾病血液透析临床剖析 　　【摘要】 目的 探讨血液透析对老年终末期肾病患者在实际治疗过程中的临床疗效。方法 60例≥65岁终末期肾病患者， 随机分为实验组和对照组， 各30例。对照组给予常规治疗， 实验组给予血液透析治疗。比较两组患者的治疗效果以及死亡率。结果 治疗后， 两组均无显效病例， 实验组有效28例， 无效1例， 死亡1例；对照组有效22例， 无效2例， 死亡6例。实验组治疗总有效率为93.33%， 明显高于对照组的73.33%， 差异具有统计学意义（P0.05）；实验组死亡率3.33%， 明显低于对照组的20.00%， 差异具有统计学意义（P0.05）。结论 在临床对老年终末期肾病患者进行治疗的过程中， 使用血液透析的方法能够显著提升患者的治疗效果并降低患者的死亡率， 在临床上值得推广应用。 　　【关键词】 终末期肾病；血液透析；老年人；临床分析 　　DOI：10.14163/j.cnki.11-5547/r.2016.34.038 　　Clinical analysis of hemodialysis for elderly end-stage renal disease XUN Kang. Department of Kidney Internal Medicine， Zhenjiang First People’s Hospital， Zhenjiang 212002， China 　　【Abstract】 Objective To explore clinical effect of hemodialysis for elderly end-stage renal disease. Methods A total of 60 patients with end-stage renal disease aged 65 years old or more were randomly divided into experimental group and control group， with 30 cases in each group. The control group received conventional therapy， and experimental group received hemodialysis. Comparison were made on curative effect and mortality. Results Both groups had 0 excellent case after treatment， the experimental group had 28 effective cases， 1 ineffective case and 1 dead case. The control group had 22 effective cases， 2 ineffective cases and 6 dead cases. The experimental group had total effective rate as 93.33%， which was higher than 73.33% in control group， and difference had statistical significance （P0.05）. The experimental group had a lower mortality as 3.33% than 20.00% in control group， and difference had statistical significance （P0.05）. Conclusion Implement of hemodialysis for elderly end-stage renal disease can increase clinical effect and decrease mortality， and this method is worth clinical promotion and application. 　　【Key words】 End-stage renal disease； Hemodialysis； Elderly； Clinical analysis 　　?S着人口老龄化趋势的加快， 老年人终末期肾病（end-stage renal disease， ESRD）发病率也在增长， 接受血液透析者随之增多[1]。对于老年患者来说， 终末期肾病患者往往会出现较多的并发症， 危害患者身体健康[2]。本院透析中心使用血液透析对老年终末期肾病患者进行治疗， 现报告如下。